Free Trial

Maxim Group's Rating of 20/20 Biolabs on 5/11/2026

On May 11, 2026, Maxim Group updated its outlook on 20/20 Biolabs (NASDAQ:AIDX) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Maxim Group

DateCompanyAction
5/14/2026
SeaStar Medical Holding Corporation stock logo
ICU
SeaStar Medical
Set Price Target
5/14/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
Set Price Target
5/12/2026
Cleanspark, Inc. stock logo
CLSK
Cleanspark
Boost Price Target
5/11/2026
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
Initiated Coverage
5/11/2026
Longeveron Inc. stock logo
LGVN
Longeveron
Downgrade
5/11/2026
Emerald Holding, Inc. stock logo
EEX
Emerald
Downgrade
More Ratings From Maxim Group